BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses

TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers

(2012) Kelly Barrios et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Interferon   limits the effectiveness of melanoma peptide vaccines

(2010) H.-I. Cho et al.   BLOOD

Overcoming doubts and other obstacles in the development of effective peptide-based therapeutic vaccines against cancer

(2010) Hyun-Il Cho et al.   Expert Review of Vaccines

Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C)

(2010) Darin A. Wick et al.   VACCINE

Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects

(2009) H.-I. Cho et al.   CANCER RESEARCH

Amphiphilic peptides and their cross-disciplinary role as building blocks for nanoscience

(2009) Silvia Cavalli et al.   CHEMICAL SOCIETY REVIEWS

In vivo Expansion, Persistence, and Function of Peptide Vaccine-Induced CD8 T Cells Occur Independently of CD4 T Cells

(2008) D. Assudani et al.   CANCER RESEARCH